Ascent Pharmaceuticals, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Aug 9, 2024
  • No warning letters matched by name
Inspections 9 0 OAI
Recalls 3 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Ascent Pharmaceuticals, Inc. has 3 FDA recalls, 9 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Ascent Pharmaceuticals, Inc." is on file.

What these totals cover: FDA records filed under the name "Ascent Pharmaceuticals, Inc." and its spelling variant "Ascent Pharmaceuticals".

Latest recall
D-0276-2022 · Class II · Nov 19, 2021
Latest inspection
Aug 9, 2024 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls3Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections9Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Ascent Pharmaceuticals, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Ascent Pharmaceuticals, Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 3 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 1 inspection (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202410000
202300000
202210000
202100010
202010010
201900000
201830010
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Ascent Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Ascent Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

3 recall records from Jan 22, 2018 to Nov 19, 2021.

NumberClassProductDate
D-0276-2022Class IIHydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only…Nov 19, 2021
D-0097-2021Class IIHydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only…Oct 26, 2020
D-0248-2018Class IIIOxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber…Jan 22, 2018

Recent FDA inspections

9 inspections from Dec 6, 2012 to Aug 9, 2024.

DateSiteProductClassificationFEI
Aug 9, 2024Central Islip, NYDrugsVoluntary Action Indicated (VAI)3009518416
Sep 15, 2022Central Islip, NYDrugsVoluntary Action Indicated (VAI)3009518416
Oct 13, 2020Central Islip, NYDrugsVoluntary Action Indicated (VAI)3009518416
Nov 7, 2018Central Islip, NYDrugsNo Action Indicated (NAI)3009518416
Jul 27, 2018Central Islip, NYDrugsNo Action Indicated (NAI)3009518416
Feb 21, 2018Central Islip, NYDrugsNo Action Indicated (NAI)3009518416
Nov 9, 2015Central Islip, NYDrugsVoluntary Action Indicated (VAI)3009518416
Sep 26, 2013Central Islip, NYDrugsVoluntary Action Indicated (VAI)3009518416
Dec 6, 2012Central Islip, NYDrugsVoluntary Action Indicated (VAI)3009518416
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3009518416Central Islip, NY9Aug 9, 2024

Ascent Pharmaceuticals, Inc. and the FDA: common questions

Has Ascent Pharmaceuticals, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Ascent Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Ascent Pharmaceuticals, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Ascent Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Ascent Pharmaceuticals, Inc.?

The most recent FDA inspection on file ended Aug 9, 2024 at Central Islip, NY and was classified VAI. FDA has 9 inspections of Ascent Pharmaceuticals, Inc. on file.

Has Ascent Pharmaceuticals, Inc. had an FDA recall?

Yes. Ascent Pharmaceuticals, Inc. has 3 FDA recalls on record. The most recent started Nov 19, 2021.

Need more than this page shows? Ask about Ascent Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.